🔎 Trials Near Me

Home › Psoriatic Arthritis › Tennessee

Pag-aaral pangklinika para sa Psoriatic Arthritis sa Tennessee

7 pag-aaral para sa Psoriatic Arthritis ang naghahanap ng mga kalahok sa mga site sa Tennessee.

Mga Lungsod sa Tennessee

Opisyal na teksto ng pag-aaral (English)

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

  • West Tennessee Research Institute, Jackson
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06671483

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

  • Clinical Site, Jackson
  • Clinical Site, Memphis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06641089

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

  • West Tennessee Research Institute, Jackson
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07286058

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

  • Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT02418442

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

  • Pa0019 116, Jackson
  • Pa0019 138, Murfreesboro
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT07290036

Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

  • Private Practice - Dr. Ramesh C. Gupta I /ID# 272897, Memphis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT06865105

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

  • Cumberland Rheumatology, Crossville
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 9, 2025 · NCT05669833

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.